Organisation paid for research Program year 2021 Source: CMS Open Payments

Albemarle Clinical Trials

Neither a doctor nor a teaching hospital

Research payments

$183,645

38 payments

Through program year 2021, Albemarle Clinical Trials is reported as receiving $183,645 in research payments, across 38 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$29,943	14
2020	Research	$75,962	11
2019	Research	$77,740	13

Breakdown

Who paid Research payments · program years 2019–2021

Glaukos Corporation $183,645 38 payments

Studies the money was for Research payments · program years 2019–2021

Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5 $77,740 13 payments
Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5% $75,962 11 payments
Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5 $29,943 14 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.